FAP and gastric cancer: Given the crucial role of immune evasion in gastric cancer resistance to PD-1 monoclonal antibody therapy, we conducted immunohistochemical analysis of FAP+CAF expression levels in tumor tissues from 20 gastric cancer patients who received first-line anti-PD-1 therapy [Supplementary Table 1].